Erivedge Interactions
There are 62 drugs known to interact with Erivedge (vismodegib), along with 1 disease interaction. Of the total drug interactions, 38 are moderate, and 24 are minor.
- View all 62 medications that may interact with Erivedge
- View Erivedge disease interactions (1)
Most frequently checked interactions
View interaction reports for Erivedge (vismodegib) and the medicines listed below.
- Actemra (tocilizumab)
- Adcirca (tadalafil)
- allopurinol
- amiodarone
- Aranesp (darbepoetin alfa)
- aspirin
- atorvastatin
- Aubagio (teriflunomide)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Blincyto (blinatumomab)
- Bosulif (bosutinib)
- Caprelsa (vandetanib)
- clonazepam
- Copaxone (glatiramer)
- Cosentyx (secukinumab)
- Cymbalta (duloxetine)
- Dupixent (dupilumab)
- Eliquis (apixaban)
- Eloctate (antihemophilic factor)
- Entyvio (vedolizumab)
- Esbriet (pirfenidone)
- Imbruvica (ibrutinib)
- metformin
- omeprazole
- Otezla (apremilast)
- prednisone
- Pulmozyme (dornase alfa)
- Sabril (vigabatrin)
- Vitamin D3 (cholecalciferol)
- Xgeva (denosumab)
Erivedge disease interactions
There is 1 disease interaction with Erivedge (vismodegib) which include:
More about Erivedge (vismodegib)
- Erivedge consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: hedgehog pathway inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.